Vascular effects of arachidonic acid in the rat perfused heart: Role of the endothelium, cyclooxygenase, cytochrome P450, and K+ channels

Journal of Lipid Research

Volumn 40, Issue 12, 1999, Pages 2177-2184

  Qiu, Y ^a   Quilley, J ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Basal versus elevated perfusion pressure; Clotrimazole; Constrictor and dilator components; Indomethacin; Tetraethylammonium; TP receptor antagonism

Indexed keywords

ARACHIDONIC ACID; CLOTRIMAZOLE; CYTOCHROME P450; POTASSIUM CHANNEL; PROSTAGLANDIN SYNTHASE; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RESPONSE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; EFFECTOR CELL; ENDOTHELIUM CELL; ENZYME INHIBITION; HEART PERFUSION; HYPERPOLARIZATION; METABOLIC ACTIVATION; MICROVASCULATURE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0033391069     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-2275(20)32092-7     Document Type: Article

References (26)

1. Quilley, J., C. P. Quilley, and J. C. McGiff. 1990. Eicosanoids and hypertension. In Hypertension: Pathophysiology, Diagnosis and Management. J. H. Laragh and B. M. Brenner, editors. Raven Press Ltd., New York, 829-840.
2. Gerritsen, M. E., and C. D. Cheli. 1983. Arachidonic acid and prostaglandin endoperoxide metabolism in isolated rabbit coronary microvessels and isolated and cultivated coronary microvessel endothelial cells. J. Clin. Invest. 72: 1658-1671.
3. 2 and prostacyclin. Pharmacol. Rev. 30: 293-320.
4. Pinto, A., N. G. Abraham, and K. M. Mullane. 1986. Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P450-dependent pathway. J. Pharmacol. Exp. Ther. 240: 856-863.
5. Oyekan, A. O., J. C. McGiff, and J. Quilley. 1991. Cytochrome P450-dependent vasodilator responses to arachidonic acid in the isolated perfused kidney of the rat. Circ. Res. 68: 958-965.
6. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am. J. Physiol. 264: H327-H335.
7. + channels in the vasodilator response to bradykinin in the rat heart. Br. J. Pharmacol. 113: 954-958.
8. Fulton, D., K. Mahboubi, J. C. McGiff, and J. Quilley. 1995. Cytochronic P450-dependent effects of bradykinin in the rat heart. Br. J. Pharmacol. 114: 99-102.
9. Hecker, M., A. T. Bara, J. Bauersachs, and R. Busse. 1994. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. 481: 407-414.
10. Bauersachs, J., M. Hecker, and R. Busse. 1994. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br. J. Pharmacol. 113: 1548-1553.
11. Campbell, W. B., D. Gebremedhin, P. F. Pratt, and D. R. Harder. 1996. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78: 415-423.
12. Quilley, J., J. C. McGiff, and A. Nasjletti. 1989. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Br. J. Pharmacol. 96: 111-116.
13. + channels to arachidonic acid-induced endothelium-dependent vasodilation in rat isolated perfused mesenteric arteries. J. Pharmacol. Exp. Ther. 258: 452-458.
14. Fulton, D., and J. Quilley. 1998. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. J. Pharmacol. Exp. Ther. 286: 1146-1151.
15. Shaffer, J. E., L. M. Cagen, and K. U. Malik. 1981. Attenuation by acetaminophen of arachidonic acid-induced coronary vasodilation and output of prostaglandins in the isolated rat heart. Eur. J. Pharmacol. 72: 57-61.
16. Belo, S. E. and J. Talesnik. 1982. Coronary vasoconstrictor and vasodilator actions of arachidonic acid in the isolated perfused heart of the rat. Br. J. Pharmacol. 75: 269-286.
17. Shaffer, J. E., and K. U. Malik. 1984. Mechanism of action of arachidonic acid in the isolated perfused rat heart. Can. J. Physiol. Pharmacol. 62: 551-558.
18. Talesnik, J., and J. N. Tsoporis. 1984. Reduced glutathione modulates arachidonic acid induced coronary reactions. Can. J. Physiol. Pharmacol. 62: 1261-1267.
19. Fulton, D., J. C. McGiff, and J. Quilley. 1992. Contribution of NO and cytochrome P450 to vasodilator effect of bradykinin in the rat kidney. Br. J. Pharmacol. 107: 722-725.
20. + channels by cytochrome P450 inhibitors. J. Biol. Chem. 267: 11789-11793.
21. Zygmunt, P. M., G. Edwards, A. H. Weston, S. C. Davis, and E. D. Hogestatt. 1996. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br. J. Pharmacol. 118: 1147-1152.
22. Fulton, D., J. C. McGiff, and J. Quilley. 1998. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric-oxide independent vasodilator effect of bradykinin in the rat heart. J. Pharmacol. Exp. Ther. 287: 497-503.
23. Kuriyama, H., K. Kitamura, and H. Nabata. 1995. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol. Rev. 47: 391-573.
24. Quilley, J., and J. C. McGiff. 1990. Study of tachyphylaxis to the vasoconstrictor effect of arachidonic acid in the isolated perfused kidney of the rat. J. Pharmacol. Exp. Ther. 252: 241-245.
25. 2 in nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart. J. Pharmacol. Exp. Ther. 278: 518-526.
26. Weintraub, N. L., S. N. Joshi, C. A. Branch, A. H. Stephenson, R. S. Sprague, and A. J. Lonigro. 1994. Relaxation porcine coronary artery to bradykinin. Role of arachidonic acid. Hypertension. 26: 684-690.